SLGCW
SomaLogic IncNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
$-0.53
Beta
1.64
52W High
$0.00
52W Low
$0.00
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-159.50%
Forward P/E
—
PEG Ratio
—
About SomaLogic Inc
SomaLogic Inc. is an innovative leader in the field of proteomics, dedicated to revolutionizing healthcare through its proprietary SomaSignal technology, which facilitates precise and predictive health assessments by analyzing a comprehensive array of biomarkers. The company's advanced platform supports a wide range of applications, including diagnostics, therapeutics, and personalized medicine, thereby enhancing the ability of healthcare providers to make informed treatment decisions. With a strong pipeline of products and strategic partnerships, SomaLogic is uniquely positioned to significantly impact disease understanding and treatment, paving the way for improved health outcomes and transformative advancements in modern medicine.
Fundamentals
| Revenue (TTM) | $81.72M |
| Gross Profit (TTM) | 0 |
| EBITDA | $-134.86M |
| Operating Margin | -108.50% |
| Return on Equity | -23.70% |
| Return on Assets | -14.20% |
| Revenue/Share (TTM) | $0.44 |
| Book Value | $2.63 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -47.10% |
| Shares Outstanding | 0 |
| Float | $153.26M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026